4WEALTH Advisors Inc. Lowers Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

4WEALTH Advisors Inc. decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 49.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 829 shares of the medical equipment provider's stock after selling 795 shares during the quarter. 4WEALTH Advisors Inc.'s holdings in Intuitive Surgical were worth $411,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of ISRG. Brighton Jones LLC boosted its stake in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after acquiring an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG boosted its stake in Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after acquiring an additional 883 shares in the last quarter. TD Private Client Wealth LLC boosted its stake in Intuitive Surgical by 8.1% during the fourth quarter. TD Private Client Wealth LLC now owns 3,988 shares of the medical equipment provider's stock worth $2,082,000 after acquiring an additional 299 shares in the last quarter. Plancorp LLC bought a new stake in Intuitive Surgical during the fourth quarter worth about $224,000. Finally, Hillsdale Investment Management Inc. boosted its stake in Intuitive Surgical by 40.1% during the fourth quarter. Hillsdale Investment Management Inc. now owns 699 shares of the medical equipment provider's stock worth $365,000 after acquiring an additional 200 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $2.50 during trading on Monday, reaching $516.12. 1,638,346 shares of the company's stock traded hands, compared to its average volume of 1,666,208. The firm has a market cap of $184.99 billion, a price-to-earnings ratio of 81.42, a price-to-earnings-growth ratio of 5.50 and a beta of 1.64. The company's 50 day simple moving average is $535.90 and its two-hundred day simple moving average is $536.29. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same quarter in the previous year, the firm earned $1.50 EPS. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently issued reports on ISRG shares. Royal Bank Of Canada dropped their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Evercore ISI increased their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. BTIG Research set a $566.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, July 14th. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price objective for the company from $515.00 to $440.00 in a research report on Monday, June 9th. Finally, Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $592.86.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company's stock in a transaction on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president directly owned 5,224 shares in the company, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the transaction, the executive vice president owned 2,245 shares of the company's stock, valued at $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.